nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.314	0.461	CbGbCtD
Naproxen—SLC22A6—Furosemide—dilated cardiomyopathy	0.13	0.191	CbGbCtD
Naproxen—CYP2C8—Spironolactone—dilated cardiomyopathy	0.125	0.184	CbGbCtD
Naproxen—ALB—Furosemide—dilated cardiomyopathy	0.111	0.163	CbGbCtD
Naproxen—CYP2C9—cardial valve—dilated cardiomyopathy	0.0105	0.489	CbGeAlD
Naproxen—AKR1C3—cardiac ventricle—dilated cardiomyopathy	0.00229	0.106	CbGeAlD
Naproxen—AKR1C3—myocardium—dilated cardiomyopathy	0.00215	0.1	CbGeAlD
Naproxen—AKR1C3—heart—dilated cardiomyopathy	0.0015	0.0698	CbGeAlD
Naproxen—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0013	0.00436	CcSEcCtD
Naproxen—AKR1C3—cardiac atrium—dilated cardiomyopathy	0.00128	0.0597	CbGeAlD
Naproxen—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00127	0.00426	CcSEcCtD
Naproxen—Urine output increased—Furosemide—dilated cardiomyopathy	0.00122	0.00411	CcSEcCtD
Naproxen—Bladder pain—Furosemide—dilated cardiomyopathy	0.00122	0.00411	CcSEcCtD
Naproxen—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00121	0.00406	CcSEcCtD
Naproxen—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00118	0.00396	CcSEcCtD
Naproxen—Mental disability—Furosemide—dilated cardiomyopathy	0.00117	0.00394	CcSEcCtD
Naproxen—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00115	0.00388	CcSEcCtD
Naproxen—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00114	0.00383	CcSEcCtD
Naproxen—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00113	0.00381	CcSEcCtD
Naproxen—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00113	0.00379	CcSEcCtD
Naproxen—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00112	0.00375	CcSEcCtD
Naproxen—Polyuria—Furosemide—dilated cardiomyopathy	0.00112	0.00375	CcSEcCtD
Naproxen—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00112	0.00375	CcSEcCtD
Naproxen—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00112	0.00375	CcSEcCtD
Naproxen—Swelling—Furosemide—dilated cardiomyopathy	0.00111	0.00374	CcSEcCtD
Naproxen—Cough increased—Lisinopril—dilated cardiomyopathy	0.00111	0.00372	CcSEcCtD
Naproxen—Alopecia—Spironolactone—dilated cardiomyopathy	0.0011	0.0037	CcSEcCtD
Naproxen—Oliguria—Lisinopril—dilated cardiomyopathy	0.0011	0.0037	CcSEcCtD
Naproxen—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0011	0.00369	CcSEcCtD
Naproxen—Deafness—Furosemide—dilated cardiomyopathy	0.0011	0.00369	CcSEcCtD
Naproxen—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00109	0.00365	CcSEcCtD
Naproxen—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00104	0.00351	CcSEcCtD
Naproxen—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00104	0.00349	CcSEcCtD
Naproxen—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00104	0.00349	CcSEcCtD
Naproxen—Thirst—Furosemide—dilated cardiomyopathy	0.00103	0.00346	CcSEcCtD
Naproxen—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00103	0.00345	CcSEcCtD
Naproxen—Neck pain—Lisinopril—dilated cardiomyopathy	0.00103	0.00345	CcSEcCtD
Naproxen—Purpura—Furosemide—dilated cardiomyopathy	0.00102	0.00342	CcSEcCtD
Naproxen—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00101	0.00341	CcSEcCtD
Naproxen—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00101	0.00339	CcSEcCtD
Naproxen—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000997	0.00335	CcSEcCtD
Naproxen—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000991	0.00333	CcSEcCtD
Naproxen—Wheezing—Lisinopril—dilated cardiomyopathy	0.000985	0.00331	CcSEcCtD
Naproxen—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000985	0.00331	CcSEcCtD
Naproxen—Malaise—Spironolactone—dilated cardiomyopathy	0.00098	0.00329	CcSEcCtD
Naproxen—Cystitis—Lisinopril—dilated cardiomyopathy	0.00098	0.00329	CcSEcCtD
Naproxen—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000973	0.00327	CcSEcCtD
Naproxen—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000958	0.00322	CcSEcCtD
Naproxen—Urinary retention—Furosemide—dilated cardiomyopathy	0.000933	0.00314	CcSEcCtD
Naproxen—ALB—heart—dilated cardiomyopathy	0.000932	0.0433	CbGeAlD
Naproxen—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00092	0.00309	CcSEcCtD
Naproxen—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000917	0.00308	CcSEcCtD
Naproxen—Discomfort—Spironolactone—dilated cardiomyopathy	0.000914	0.00307	CcSEcCtD
Naproxen—Dehydration—Furosemide—dilated cardiomyopathy	0.000913	0.00307	CcSEcCtD
Naproxen—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000908	0.00305	CcSEcCtD
Naproxen—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000903	0.00303	CcSEcCtD
Naproxen—Confusional state—Spironolactone—dilated cardiomyopathy	0.000894	0.003	CcSEcCtD
Naproxen—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000893	0.003	CcSEcCtD
Naproxen—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000889	0.00299	CcSEcCtD
Naproxen—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000887	0.00298	CcSEcCtD
Naproxen—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000884	0.00297	CcSEcCtD
Naproxen—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000884	0.00297	CcSEcCtD
Naproxen—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000868	0.00292	CcSEcCtD
Naproxen—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000866	0.00291	CcSEcCtD
Naproxen—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000854	0.00287	CcSEcCtD
Naproxen—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000847	0.00284	CcSEcCtD
Naproxen—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00084	0.00282	CcSEcCtD
Naproxen—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000839	0.00282	CcSEcCtD
Naproxen—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000832	0.00279	CcSEcCtD
Naproxen—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000831	0.00279	CcSEcCtD
Naproxen—Eczema—Lisinopril—dilated cardiomyopathy	0.00082	0.00275	CcSEcCtD
Naproxen—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00082	0.00275	CcSEcCtD
Naproxen—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000816	0.00274	CcSEcCtD
Naproxen—Somnolence—Spironolactone—dilated cardiomyopathy	0.000788	0.00265	CcSEcCtD
Naproxen—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000784	0.00263	CcSEcCtD
Naproxen—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000774	0.0026	CcSEcCtD
Naproxen—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000774	0.0026	CcSEcCtD
Naproxen—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000766	0.00257	CcSEcCtD
Naproxen—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000765	0.00257	CcSEcCtD
Naproxen—PTGS1—myocardium—dilated cardiomyopathy	0.000761	0.0354	CbGeAlD
Naproxen—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000761	0.00256	CcSEcCtD
Naproxen—Drowsiness—Furosemide—dilated cardiomyopathy	0.000756	0.00254	CcSEcCtD
Naproxen—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000755	0.00253	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00075	0.00252	CcSEcCtD
Naproxen—Renal failure—Furosemide—dilated cardiomyopathy	0.000744	0.0025	CcSEcCtD
Naproxen—Diplopia—Lisinopril—dilated cardiomyopathy	0.000737	0.00247	CcSEcCtD
Naproxen—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000737	0.00247	CcSEcCtD
Naproxen—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000731	0.00245	CcSEcCtD
Naproxen—Sweating—Furosemide—dilated cardiomyopathy	0.000725	0.00244	CcSEcCtD
Naproxen—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000715	0.0024	CcSEcCtD
Naproxen—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000706	0.00237	CcSEcCtD
Naproxen—Urticaria—Spironolactone—dilated cardiomyopathy	0.000704	0.00237	CcSEcCtD
Naproxen—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000701	0.00235	CcSEcCtD
Naproxen—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00069	0.00232	CcSEcCtD
Naproxen—Dehydration—Lisinopril—dilated cardiomyopathy	0.000685	0.0023	CcSEcCtD
Naproxen—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000671	0.00225	CcSEcCtD
Naproxen—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000666	0.00224	CcSEcCtD
Naproxen—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000666	0.00224	CcSEcCtD
Naproxen—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000663	0.00223	CcSEcCtD
Naproxen—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000663	0.00223	CcSEcCtD
Naproxen—Visual impairment—Furosemide—dilated cardiomyopathy	0.000654	0.0022	CcSEcCtD
Naproxen—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000653	0.00219	CcSEcCtD
Naproxen—Gastritis—Lisinopril—dilated cardiomyopathy	0.000652	0.00219	CcSEcCtD
Naproxen—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000642	0.00216	CcSEcCtD
Naproxen—Asthma—Lisinopril—dilated cardiomyopathy	0.000637	0.00214	CcSEcCtD
Naproxen—Influenza—Lisinopril—dilated cardiomyopathy	0.000637	0.00214	CcSEcCtD
Naproxen—Eye disorder—Furosemide—dilated cardiomyopathy	0.000635	0.00213	CcSEcCtD
Naproxen—Tinnitus—Furosemide—dilated cardiomyopathy	0.000633	0.00213	CcSEcCtD
Naproxen—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00063	0.00212	CcSEcCtD
Naproxen—Pruritus—Spironolactone—dilated cardiomyopathy	0.000627	0.00211	CcSEcCtD
Naproxen—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000624	0.0021	CcSEcCtD
Naproxen—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00062	0.00208	CcSEcCtD
Naproxen—Angiopathy—Furosemide—dilated cardiomyopathy	0.000616	0.00207	CcSEcCtD
Naproxen—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000613	0.00206	CcSEcCtD
Naproxen—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000612	0.00206	CcSEcCtD
Naproxen—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000607	0.00204	CcSEcCtD
Naproxen—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000607	0.00204	CcSEcCtD
Naproxen—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000605	0.00203	CcSEcCtD
Naproxen—Dysuria—Lisinopril—dilated cardiomyopathy	0.000595	0.002	CcSEcCtD
Naproxen—Malnutrition—Furosemide—dilated cardiomyopathy	0.000591	0.00199	CcSEcCtD
Naproxen—Erythema—Furosemide—dilated cardiomyopathy	0.000591	0.00199	CcSEcCtD
Naproxen—Dizziness—Spironolactone—dilated cardiomyopathy	0.000586	0.00197	CcSEcCtD
Naproxen—Flatulence—Furosemide—dilated cardiomyopathy	0.000583	0.00196	CcSEcCtD
Naproxen—CYP2C9—heart—dilated cardiomyopathy	0.000582	0.027	CbGeAlD
Naproxen—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000581	0.00195	CcSEcCtD
Naproxen—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000576	0.00193	CcSEcCtD
Naproxen—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000574	0.00193	CcSEcCtD
Naproxen—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000571	0.00192	CcSEcCtD
Naproxen—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000568	0.00191	CcSEcCtD
Naproxen—Depression—Lisinopril—dilated cardiomyopathy	0.000566	0.0019	CcSEcCtD
Naproxen—Vomiting—Spironolactone—dilated cardiomyopathy	0.000564	0.00189	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000563	0.00189	CcSEcCtD
Naproxen—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00056	0.00188	CcSEcCtD
Naproxen—Rash—Spironolactone—dilated cardiomyopathy	0.000559	0.00188	CcSEcCtD
Naproxen—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000559	0.00188	CcSEcCtD
Naproxen—Renal failure—Lisinopril—dilated cardiomyopathy	0.000558	0.00187	CcSEcCtD
Naproxen—Vision blurred—Furosemide—dilated cardiomyopathy	0.000557	0.00187	CcSEcCtD
Naproxen—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000556	0.00187	CcSEcCtD
Naproxen—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000556	0.00187	CcSEcCtD
Naproxen—Headache—Spironolactone—dilated cardiomyopathy	0.000556	0.00187	CcSEcCtD
Naproxen—Jaundice—Lisinopril—dilated cardiomyopathy	0.000553	0.00186	CcSEcCtD
Naproxen—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000552	0.00185	CcSEcCtD
Naproxen—Anaemia—Furosemide—dilated cardiomyopathy	0.000546	0.00184	CcSEcCtD
Naproxen—Sweating—Lisinopril—dilated cardiomyopathy	0.000544	0.00183	CcSEcCtD
Naproxen—Haematuria—Lisinopril—dilated cardiomyopathy	0.000541	0.00182	CcSEcCtD
Naproxen—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000537	0.0018	CcSEcCtD
Naproxen—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000535	0.0018	CcSEcCtD
Naproxen—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000532	0.00179	CcSEcCtD
Naproxen—PTGS1—heart—dilated cardiomyopathy	0.000531	0.0247	CbGeAlD
Naproxen—Vertigo—Furosemide—dilated cardiomyopathy	0.000531	0.00178	CcSEcCtD
Naproxen—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00053	0.00178	CcSEcCtD
Naproxen—Leukopenia—Furosemide—dilated cardiomyopathy	0.000529	0.00178	CcSEcCtD
Naproxen—Nausea—Spironolactone—dilated cardiomyopathy	0.000527	0.00177	CcSEcCtD
Naproxen—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000511	0.00172	CcSEcCtD
Naproxen—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00051	0.00171	CcSEcCtD
Naproxen—PTGS2—heart—dilated cardiomyopathy	0.000508	0.0236	CbGeAlD
Naproxen—Hallucination—Lisinopril—dilated cardiomyopathy	0.000507	0.0017	CcSEcCtD
Naproxen—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000506	0.0017	CcSEcCtD
Naproxen—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000503	0.00169	CcSEcCtD
Naproxen—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000502	0.00169	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0005	0.00168	CcSEcCtD
Naproxen—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000499	0.00168	CcSEcCtD
Naproxen—Dry mouth—Furosemide—dilated cardiomyopathy	0.000492	0.00165	CcSEcCtD
Naproxen—Confusional state—Furosemide—dilated cardiomyopathy	0.000486	0.00163	CcSEcCtD
Naproxen—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000482	0.00162	CcSEcCtD
Naproxen—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000482	0.00162	CcSEcCtD
Naproxen—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000475	0.0016	CcSEcCtD
Naproxen—Shock—Furosemide—dilated cardiomyopathy	0.000475	0.00159	CcSEcCtD
Naproxen—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000473	0.00159	CcSEcCtD
Naproxen—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000472	0.00159	CcSEcCtD
Naproxen—Skin disorder—Furosemide—dilated cardiomyopathy	0.000469	0.00157	CcSEcCtD
Naproxen—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000466	0.00157	CcSEcCtD
Naproxen—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000462	0.00155	CcSEcCtD
Naproxen—Anorexia—Furosemide—dilated cardiomyopathy	0.00046	0.00154	CcSEcCtD
Naproxen—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000459	0.00154	CcSEcCtD
Naproxen—Chills—Lisinopril—dilated cardiomyopathy	0.000457	0.00154	CcSEcCtD
Naproxen—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000455	0.00153	CcSEcCtD
Naproxen—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000454	0.0211	CbGeAlD
Naproxen—Hypotension—Furosemide—dilated cardiomyopathy	0.000451	0.00151	CcSEcCtD
Naproxen—Alopecia—Lisinopril—dilated cardiomyopathy	0.00045	0.00151	CcSEcCtD
Naproxen—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000446	0.0015	CcSEcCtD
Naproxen—Erythema—Lisinopril—dilated cardiomyopathy	0.000444	0.00149	CcSEcCtD
Naproxen—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000444	0.00149	CcSEcCtD
Naproxen—Flatulence—Lisinopril—dilated cardiomyopathy	0.000437	0.00147	CcSEcCtD
Naproxen—Tension—Lisinopril—dilated cardiomyopathy	0.000435	0.00146	CcSEcCtD
Naproxen—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000433	0.00146	CcSEcCtD
Naproxen—Nervousness—Lisinopril—dilated cardiomyopathy	0.000431	0.00145	CcSEcCtD
Naproxen—Somnolence—Furosemide—dilated cardiomyopathy	0.000429	0.00144	CcSEcCtD
Naproxen—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000426	0.00143	CcSEcCtD
Naproxen—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000419	0.00141	CcSEcCtD
Naproxen—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000418	0.0014	CcSEcCtD
Naproxen—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000417	0.0014	CcSEcCtD
Naproxen—Fatigue—Furosemide—dilated cardiomyopathy	0.000416	0.0014	CcSEcCtD
Naproxen—Tremor—Lisinopril—dilated cardiomyopathy	0.000416	0.0014	CcSEcCtD
Naproxen—Pain—Furosemide—dilated cardiomyopathy	0.000413	0.00139	CcSEcCtD
Naproxen—Constipation—Furosemide—dilated cardiomyopathy	0.000413	0.00139	CcSEcCtD
Naproxen—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000412	0.00138	CcSEcCtD
Naproxen—Anaemia—Lisinopril—dilated cardiomyopathy	0.00041	0.00138	CcSEcCtD
Naproxen—Angioedema—Lisinopril—dilated cardiomyopathy	0.000405	0.00136	CcSEcCtD
Naproxen—Malaise—Lisinopril—dilated cardiomyopathy	0.0004	0.00134	CcSEcCtD
Naproxen—Vertigo—Lisinopril—dilated cardiomyopathy	0.000398	0.00134	CcSEcCtD
Naproxen—Syncope—Lisinopril—dilated cardiomyopathy	0.000398	0.00134	CcSEcCtD
Naproxen—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000398	0.00134	CcSEcCtD
Naproxen—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000397	0.00133	CcSEcCtD
Naproxen—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000395	0.00133	CcSEcCtD
Naproxen—Palpitations—Lisinopril—dilated cardiomyopathy	0.000392	0.00132	CcSEcCtD
Naproxen—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00039	0.00131	CcSEcCtD
Naproxen—Cough—Lisinopril—dilated cardiomyopathy	0.000387	0.0013	CcSEcCtD
Naproxen—Urticaria—Furosemide—dilated cardiomyopathy	0.000383	0.00129	CcSEcCtD
Naproxen—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000381	0.00128	CcSEcCtD
Naproxen—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000381	0.00128	CcSEcCtD
Naproxen—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000378	0.00127	CcSEcCtD
Naproxen—Chest pain—Lisinopril—dilated cardiomyopathy	0.000378	0.00127	CcSEcCtD
Naproxen—Myalgia—Lisinopril—dilated cardiomyopathy	0.000378	0.00127	CcSEcCtD
Naproxen—Anxiety—Lisinopril—dilated cardiomyopathy	0.000376	0.00126	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000375	0.00126	CcSEcCtD
Naproxen—Discomfort—Lisinopril—dilated cardiomyopathy	0.000373	0.00125	CcSEcCtD
Naproxen—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000369	0.00124	CcSEcCtD
Naproxen—Confusional state—Lisinopril—dilated cardiomyopathy	0.000365	0.00123	CcSEcCtD
Naproxen—Oedema—Lisinopril—dilated cardiomyopathy	0.000362	0.00122	CcSEcCtD
Naproxen—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000362	0.00122	CcSEcCtD
Naproxen—Infection—Lisinopril—dilated cardiomyopathy	0.00036	0.00121	CcSEcCtD
Naproxen—Shock—Lisinopril—dilated cardiomyopathy	0.000356	0.0012	CcSEcCtD
Naproxen—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000355	0.00119	CcSEcCtD
Naproxen—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000354	0.00119	CcSEcCtD
Naproxen—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000353	0.00119	CcSEcCtD
Naproxen—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000352	0.00118	CcSEcCtD
Naproxen—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00035	0.00118	CcSEcCtD
Naproxen—Asthenia—Furosemide—dilated cardiomyopathy	0.000346	0.00116	CcSEcCtD
Naproxen—Anorexia—Lisinopril—dilated cardiomyopathy	0.000345	0.00116	CcSEcCtD
Naproxen—Pruritus—Furosemide—dilated cardiomyopathy	0.000341	0.00115	CcSEcCtD
Naproxen—Hypotension—Lisinopril—dilated cardiomyopathy	0.000338	0.00114	CcSEcCtD
Naproxen—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00033	0.00111	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00033	0.00111	CcSEcCtD
Naproxen—Insomnia—Lisinopril—dilated cardiomyopathy	0.000327	0.0011	CcSEcCtD
Naproxen—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000325	0.00109	CcSEcCtD
Naproxen—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000323	0.00108	CcSEcCtD
Naproxen—Somnolence—Lisinopril—dilated cardiomyopathy	0.000322	0.00108	CcSEcCtD
Naproxen—Dizziness—Furosemide—dilated cardiomyopathy	0.000319	0.00107	CcSEcCtD
Naproxen—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000319	0.00107	CcSEcCtD
Naproxen—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000315	0.00106	CcSEcCtD
Naproxen—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000313	0.00105	CcSEcCtD
Naproxen—Fatigue—Lisinopril—dilated cardiomyopathy	0.000312	0.00105	CcSEcCtD
Naproxen—Constipation—Lisinopril—dilated cardiomyopathy	0.00031	0.00104	CcSEcCtD
Naproxen—Pain—Lisinopril—dilated cardiomyopathy	0.00031	0.00104	CcSEcCtD
Naproxen—Vomiting—Furosemide—dilated cardiomyopathy	0.000307	0.00103	CcSEcCtD
Naproxen—Rash—Furosemide—dilated cardiomyopathy	0.000304	0.00102	CcSEcCtD
Naproxen—Dermatitis—Furosemide—dilated cardiomyopathy	0.000304	0.00102	CcSEcCtD
Naproxen—Headache—Furosemide—dilated cardiomyopathy	0.000302	0.00102	CcSEcCtD
Naproxen—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000298	0.001	CcSEcCtD
Naproxen—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000296	0.000994	CcSEcCtD
Naproxen—Urticaria—Lisinopril—dilated cardiomyopathy	0.000288	0.000966	CcSEcCtD
Naproxen—Nausea—Furosemide—dilated cardiomyopathy	0.000287	0.000963	CcSEcCtD
Naproxen—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000286	0.000961	CcSEcCtD
Naproxen—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000286	0.000961	CcSEcCtD
Naproxen—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000267	0.000896	CcSEcCtD
Naproxen—Asthenia—Lisinopril—dilated cardiomyopathy	0.00026	0.000872	CcSEcCtD
Naproxen—Pruritus—Lisinopril—dilated cardiomyopathy	0.000256	0.00086	CcSEcCtD
Naproxen—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000248	0.000832	CcSEcCtD
Naproxen—Dizziness—Lisinopril—dilated cardiomyopathy	0.000239	0.000804	CcSEcCtD
Naproxen—Vomiting—Lisinopril—dilated cardiomyopathy	0.00023	0.000773	CcSEcCtD
Naproxen—Rash—Lisinopril—dilated cardiomyopathy	0.000228	0.000767	CcSEcCtD
Naproxen—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000228	0.000766	CcSEcCtD
Naproxen—Headache—Lisinopril—dilated cardiomyopathy	0.000227	0.000762	CcSEcCtD
Naproxen—Nausea—Lisinopril—dilated cardiomyopathy	0.000215	0.000722	CcSEcCtD
